1. Home
  2. WOR vs RDY Comparison

WOR vs RDY Comparison

Compare WOR & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WOR
  • RDY
  • Stock Information
  • Founded
  • WOR 1955
  • RDY 1984
  • Country
  • WOR United States
  • RDY India
  • Employees
  • WOR N/A
  • RDY N/A
  • Industry
  • WOR Aerospace
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • WOR Consumer Discretionary
  • RDY Health Care
  • Exchange
  • WOR Nasdaq
  • RDY Nasdaq
  • Market Cap
  • WOR 2.5B
  • RDY 2.1B
  • IPO Year
  • WOR N/A
  • RDY N/A
  • Fundamental
  • Price
  • WOR $58.14
  • RDY $13.42
  • Analyst Decision
  • WOR Buy
  • RDY Buy
  • Analyst Count
  • WOR 3
  • RDY 1
  • Target Price
  • WOR $57.00
  • RDY $17.00
  • AVG Volume (30 Days)
  • WOR 283.3K
  • RDY 2.2M
  • Earning Date
  • WOR 06-24-2025
  • RDY 05-09-2025
  • Dividend Yield
  • WOR 1.17%
  • RDY 0.71%
  • EPS Growth
  • WOR N/A
  • RDY 2.68
  • EPS
  • WOR 1.21
  • RDY 0.79
  • Revenue
  • WOR $1,154,679,000.00
  • RDY $3,809,801,863.00
  • Revenue This Year
  • WOR N/A
  • RDY $10.38
  • Revenue Next Year
  • WOR $3.49
  • RDY N/A
  • P/E Ratio
  • WOR $47.92
  • RDY $17.04
  • Revenue Growth
  • WOR N/A
  • RDY 14.74
  • 52 Week Low
  • WOR $37.88
  • RDY $12.26
  • 52 Week High
  • WOR $60.55
  • RDY $16.89
  • Technical
  • Relative Strength Index (RSI)
  • WOR 79.77
  • RDY 47.73
  • Support Level
  • WOR $48.44
  • RDY $13.17
  • Resistance Level
  • WOR $58.53
  • RDY $14.06
  • Average True Range (ATR)
  • WOR 1.47
  • RDY 0.20
  • MACD
  • WOR 0.80
  • RDY -0.07
  • Stochastic Oscillator
  • WOR 96.84
  • RDY 27.78

About WOR Worthington Enterprises Inc.

Worthington Enterprises Inc is a designer and manufacturer of products sold to consumers, through retail channels, in the tools, outdoor living and celebrations market categories as well as a wide array of specialized building products that serve customers in the residential and non-residential construction markets, including ceiling suspension systems and light gauge metal framing products, as well as wholly-owned and consolidated operations that produce pressurized containment solutions for heating, cooking and cooling applications, among others. It operates under two reportable operating segments: Consumer Products and Building Products. It derives majority of the revenue from Building Products segment.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: